Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2019
Top Cited Papers
Open Access
- 31 December 2018
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 42 (Supplement), S90-S102
- https://doi.org/10.2337/dc19-S009
Abstract
The American Diabetes Association (ADA) Standards of Medical Care in Diabetes includes ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.Keywords
This publication has 82 references indexed in Scilit:
- Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trialInternational Journal Of Clinical Practice, 2012
- Comparative glycemic control, safety and patient ratings for a new 4 mm × 32G insulin pen needle in adults with diabetesCurrent Medical Research and Opinion, 2010
- Dose-Response Effects of Insulin Glargine in Type 2 DiabetesDiabetes Care, 2010
- Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysisCMAJ : Canadian Medical Association Journal, 2009
- Short‐acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta‐analysisDiabetes, Obesity and Metabolism, 2008
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Long‐term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat‐to‐target basal–bolus regimen with insulin aspart at meals: a 2‐year, randomized, controlled trialDiabetic Medicine, 2008
- The Effect of Intensive Glycemic Treatment on Coronary Artery Calcification in Type 1 Diabetic Participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) StudyDiabetes, 2006
- A Double-Blind, Placebo-Controlled Trial Assessing Pramlintide Treatment in the Setting of Intensive Insulin Therapy in Type 1 DiabetesDiabetes Care, 2006
- Effects of Accidental Intramuscular Injection on Insulin Absorption in IDDMDiabetes Care, 1988